HTFL
Heartflow, Inc.
+0.61 (+1.26%)48.91USD414K成交股數4.3B市值16.1本益比(近四季)20.1股價營收比+47.6%營收年增(近四季)2026-11-11下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 16 · 12.3M · 3 |
| 其中 10b5-1 計畫賣出 | 16 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 310M |
| 近 180 天 淨額 | −310M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | 09-15 | Verghese Vikram | Chief Financial Officer | S 公開市場賣出(10b5-1) | 668 | 50.01 | 33K | 180K | SEC |
| 2026-09-14 | 09-15 | Verghese Vikram | Chief Financial Officer | S 公開市場賣出(10b5-1) | 4.6K | 50.24 | 231K | 180K | SEC |
| 2026-09-11 | 09-15 | Verghese Vikram | Chief Financial Officer | S 公開市場賣出(10b5-1) | 29.7K | 50.06 | 1.5M | 185K | SEC |
| 2026-09-11 | 09-14 | Farquhar John C.M. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 3.9K | 50.00 | 195K | 322K | SEC |
| 2026-09-10 | 09-14 | Farquhar John C.M. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 35.0K | 46.42 | 1.6M | 326K | SEC |
| 2026-09-08 | 09-10 | Verghese Vikram | Chief Financial Officer | S 公開市場賣出(10b5-1) | 6.6K | 50.03 | 332K | 215K | SEC |
| 2026-09-03 | 09-04 | Verghese Vikram | Chief Financial Officer | S 公開市場賣出(10b5-1) | 27.5K | 49.69 | 1.4M | 221K | SEC |
| 2026-09-02 | 09-04 | Verghese Vikram | Chief Financial Officer | S 公開市場賣出(10b5-1) | 5.9K | 50.60 | 297K | 249K | SEC |
| 2026-08-21 | 08-25 | Farquhar John C.M. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 27.2K | 50.00 | 1.4M | 361K | SEC |
| 2026-08-18 | 08-20 | Farquhar John C.M. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 32.7K | 45.00 | 1.5M | 388K | SEC |
| 2026-08-17 | 08-19 | Rogers Campbell | Chief Medical Officer | S 公開市場賣出(10b5-1) | 9.2K | 41.23 | 380K | 86.5K | SEC |
| 2026-08-17 | 08-19 | Rogers Campbell | Chief Medical Officer | M 選擇權執行 | 9.2K | 19.00 | 175K | 95.7K | SEC |
| 2026-08-14 | 08-18 | Farquhar John C.M. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 15.6K | 39.06 | 608K | 421K | SEC |
| 2026-08-10 | 08-12 | Farquhar John C.M. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 22.6K | 28.31 | 639K | 436K | SEC |
| 2026-08-07 | 08-10 | Verghese Vikram | Chief Financial Officer | F 繳稅扣股 | 473 | 28.82 | 14K | 255K | SEC |
| 2026-08-07 | 08-10 | Farquhar John C.M. | Chief Executive Officer | F 繳稅扣股 | 1.9K | 28.82 | 55K | 459K | SEC |
| 2026-08-07 | 08-10 | Jones Marie L. | Chief Accounting Officer | F 繳稅扣股 | 82 | 28.82 | 2K | 32.2K | SEC |
| 2026-08-07 | 08-10 | Rogers Campbell | Chief Medical Officer | F 繳稅扣股 | 637 | 28.82 | 18K | 86.5K | SEC |
| 2026-08-06 | 08-10 | Farquhar John C.M. | Chief Executive Officer | F 繳稅扣股 | 5.8K | 27.19 | 159K | 461K | SEC |
| 2026-08-06 | 08-10 | Rogers Campbell | Chief Medical Officer | F 繳稅扣股 | 1.6K | 27.19 | 44K | 87.1K | SEC |
| 2026-08-06 | 08-10 | Verghese Vikram | Chief Financial Officer | F 繳稅扣股 | 1.5K | 27.19 | 42K | 255K | SEC |
| 2026-08-06 | 08-10 | Jones Marie L. | Chief Accounting Officer | F 繳稅扣股 | 486 | 27.19 | 13K | 32.3K | SEC |
| 2026-07-30 | 07-31 | Farquhar John C.M. | Chief Executive Officer | M 選擇權執行 | 9.7K | 9.58 | 93K | 467K | SEC |
| 2026-07-30 | 07-31 | Farquhar John C.M. | Chief Executive Officer | M 選擇權執行 | 2.8K | 8.33 | 23K | 438K | SEC |
| 2026-07-30 | 07-31 | Farquhar John C.M. | Chief Executive Officer | M 選擇權執行 | 18.7K | 2.22 | 42K | 457K | SEC |
| 2026-07-27 | 07-28 | Verghese Vikram | Chief Financial Officer | M 選擇權執行 | 22.5K | 2.22 | 50K | 256K | SEC |
| 2026-07-24 | 07-28 | Lightcap Jeffrey C | Director | M 選擇權執行 | 47.4K | 19.00 | 901K | 294K | SEC |
| 2026-07-22 | 07-24 | BARABE TIMOTHY C | Director | M 選擇權執行 | 3.7K | 19.00 | 70K | 188K | SEC |
| 2026-07-21 | 07-23 | Verghese Vikram | Chief Financial Officer | M 選擇權執行 | 22.5K | 2.22 | 50K | 233K | SEC |
| 2026-07-17 | 07-20 | BARABE TIMOTHY C | Director | M 選擇權執行 | 5.0K | 19.00 | 95K | 185K | SEC |
| 2026-07-15 | 07-17 | Rogers Campbell | Chief Medical Officer | M 選擇權執行 | 9.2K | 19.00 | 175K | 98.0K | SEC |
| 2026-07-15 | 07-17 | Rogers Campbell | Chief Medical Officer | S 公開市場賣出(10b5-1) | 9.2K | 25.72 | 237K | 88.7K | SEC |
| 2026-07-10 | 07-13 | Farquhar John C.M. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 22.6K | 27.75 | 626K | 435K | SEC |
| 2026-07-08 | 07-10 | WELDON WILLIAM C | Director | M 選擇權執行 | 17.1K | 8.33 | 143K | 210K | SEC |
| 2026-07-08 | 07-10 | WELDON WILLIAM C | Director | M 選擇權執行 | 17.1K | 8.33 | 143K | 244K | SEC |
| 2026-07-08 | 07-10 | WELDON WILLIAM C | Director | M 選擇權執行 | 17.1K | 8.33 | 143K | 227K | SEC |
| 2026-06-24 | 06-26 | Farquhar John C.M. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 38.9K | 35.00 | 1.4M | 458K | SEC |
| 2026-06-15 | 06-17 | Rogers Campbell | Chief Medical Officer | M 選擇權執行 | 10.0K | 2.22 | 22K | 88.7K | SEC |
| 2026-06-10 | 06-12 | Farquhar John C.M. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 22.6K | 28.50 | 643K | 497K | SEC |
| 2026-05-18 | 05-20 | Rogers Campbell | Chief Medical Officer | S 公開市場賣出(10b5-1) | 9.2K | 28.34 | 261K | 78.7K | SEC |
| 2026-05-18 | 05-20 | Rogers Campbell | Chief Medical Officer | M 選擇權執行 | 9.2K | 19.00 | 175K | 88.0K | SEC |
| 2026-05-11 | 05-13 | Farquhar John C.M. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 22.6K | 29.12 | 657K | 519K | SEC |
| 2026-05-07 | 05-08 | Rogers Campbell | Chief Medical Officer | F 繳稅扣股 | 637 | 29.98 | 19K | 78.7K | SEC |
| 2026-05-07 | 05-08 | Jones Marie L. | Chief Accounting Officer | F 繳稅扣股 | 82 | 29.98 | 2K | 31.1K | SEC |
| 2026-05-07 | 05-08 | Farquhar John C.M. | Chief Executive Officer | F 繳稅扣股 | 1.9K | 29.98 | 57K | 542K | SEC |
| 2026-05-07 | 05-08 | Verghese Vikram | Chief Financial Officer | F 繳稅扣股 | 473 | 29.98 | 14K | 211K | SEC |
| 2026-05-06 | 05-08 | Verghese Vikram | Chief Financial Officer | F 繳稅扣股 | 1.5K | 30.29 | 47K | 211K | SEC |
| 2026-05-06 | 05-08 | Jones Marie L. | Chief Accounting Officer | F 繳稅扣股 | 485 | 30.29 | 15K | 31.2K | SEC |
| 2026-05-06 | 05-08 | Farquhar John C.M. | Chief Executive Officer | F 繳稅扣股 | 5.3K | 30.29 | 161K | 544K | SEC |
| 2026-05-06 | 05-08 | Rogers Campbell | Chief Medical Officer | F 繳稅扣股 | 1.6K | 30.29 | 49K | 79.4K | SEC |
| 2026-04-30 | 04-30 | BCLS Fund III Investments, LP | TenPercentOwner | S 公開市場賣出 | 893K | 29.18 | 26.0M | 8.5M | SEC |
| 2026-04-30 | 04-30 | Bain Capital Life Sciences Investors, LLC | TenPercentOwner | S 公開市場賣出 | 893K | 29.18 | 26.0M | 8.5M | SEC |
| 2026-04-30 | 04-30 | Bain Capital Life Sciences Investors, LLC | TenPercentOwner | S 公開市場賣出 | 56.2K | 30.05 | 1.7M | 8.4M | SEC |
| 2026-04-30 | 04-30 | Bain Capital Life Sciences Fund III, L.P. | TenPercentOwner | S 公開市場賣出 | 893K | 29.18 | 26.0M | 8.5M | SEC |
| 2026-04-30 | 04-30 | Bain Capital Life Sciences Fund III, L.P. | TenPercentOwner | S 公開市場賣出 | 56.2K | 30.05 | 1.7M | 8.4M | SEC |
| 2026-04-30 | 04-30 | BCLS Fund III Investments GP, LLC | TenPercentOwner | S 公開市場賣出 | 893K | 29.18 | 26.0M | 8.5M | SEC |
| 2026-04-30 | 04-30 | BCLS Fund III Investments GP, LLC | TenPercentOwner | S 公開市場賣出 | 56.2K | 30.05 | 1.7M | 8.4M | SEC |
| 2026-04-30 | 04-30 | Bain Capital Life Sciences III General Partner, LLC | TenPercentOwner | S 公開市場賣出 | 893K | 29.18 | 26.0M | 8.5M | SEC |
| 2026-04-30 | 04-30 | Bain Capital Life Sciences III General Partner, LLC | TenPercentOwner | S 公開市場賣出 | 56.2K | 30.05 | 1.7M | 8.4M | SEC |
| 2026-04-30 | 04-30 | BCLS Fund III Investments, LP | TenPercentOwner | S 公開市場賣出 | 56.2K | 30.05 | 1.7M | 8.4M | SEC |
| 2026-04-29 | 04-30 | Bain Capital Life Sciences III General Partner, LLC | TenPercentOwner | S 公開市場賣出 | 797K | 29.37 | 23.4M | 9.4M | SEC |
| 2026-04-29 | 04-30 | BCLS Fund III Investments, LP | TenPercentOwner | S 公開市場賣出 | 797K | 29.37 | 23.4M | 9.4M | SEC |
| 2026-04-29 | 04-30 | BCLS Fund III Investments GP, LLC | TenPercentOwner | S 公開市場賣出 | 797K | 29.37 | 23.4M | 9.4M | SEC |
| 2026-04-29 | 04-30 | Bain Capital Life Sciences Fund III, L.P. | TenPercentOwner | S 公開市場賣出 | 797K | 29.37 | 23.4M | 9.4M | SEC |
| 2026-04-29 | 04-30 | Bain Capital Life Sciences Investors, LLC | TenPercentOwner | S 公開市場賣出 | 797K | 29.37 | 23.4M | 9.4M | SEC |
| 2026-04-28 | 04-30 | BCLS Fund III Investments, LP | TenPercentOwner | S 公開市場賣出 | 254K | 30.51 | 7.8M | 10.2M | SEC |
| 2026-04-28 | 04-30 | Bain Capital Life Sciences Investors, LLC | TenPercentOwner | S 公開市場賣出 | 254K | 30.51 | 7.8M | 10.2M | SEC |
| 2026-04-28 | 04-30 | BCLS Fund III Investments GP, LLC | TenPercentOwner | S 公開市場賣出 | 254K | 30.51 | 7.8M | 10.2M | SEC |
| 2026-04-28 | 04-30 | Bain Capital Life Sciences Fund III, L.P. | TenPercentOwner | S 公開市場賣出 | 254K | 30.51 | 7.8M | 10.2M | SEC |
| 2026-04-28 | 04-30 | Bain Capital Life Sciences III General Partner, LLC | TenPercentOwner | S 公開市場賣出 | 254K | 30.51 | 7.8M | 10.2M | SEC |
| 2026-04-10 | 04-14 | Farquhar John C.M. | Chief Executive Officer | S 公開市場賣出(10b5-1) | 22.6K | 26.72 | 603K | 549K | SEC |
| 2026-04-01 | 04-03 | Rogers Campbell | Chief Medical Officer | M 選擇權執行 | 40.8K | 2.22 | 91K | 139K | SEC |
| 2026-04-01 | 04-03 | Rogers Campbell | Chief Medical Officer | M 選擇權執行 | 6.8K | 2.22 | 15K | 146K | SEC |
| 2026-04-01 | 04-03 | Rogers Campbell | Chief Medical Officer | M 選擇權執行 | 291 | 8.33 | 2K | 78.8K | SEC |
| 2026-04-01 | 04-03 | Rogers Campbell | Chief Medical Officer | M 選擇權執行 | 19.1K | 2.22 | 42K | 97.9K | SEC |
| 2026-04-01 | 04-03 | Rogers Campbell | Chief Medical Officer | S 公開市場賣出(10b5-1) | 64.5K | 24.64 | 1.6M | 81.0K | SEC |
| 2026-03-24 | 03-26 | HealthCor Partners Management LP | Director | J 其他 | 4.6M | – | – | 0 | SEC |
| 2026-03-24 | 03-26 | Lightcap Jeffrey C | Director | J 其他 | 206K | – | – | 246K | SEC |
| 2026-03-19 | 03-23 | Rogers Campbell | Chief Medical Officer | S 公開市場賣出(10b5-1) | 64.5K | 25.69 | 1.7M | 78.5K | SEC |
| 2026-03-19 | 03-23 | Rogers Campbell | Chief Medical Officer | M 選擇權執行 | 47.6K | 2.22 | 106K | 143K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8.4M | 248M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 7.9M | 231M | 新進 | 新進 |
| BlackRock, Inc. | 5.2M | 153M | 新進 | 新進 |
| FMR LLC | 4.8M | 141M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.6M | 105M | 新進 | 新進 |
| BAMCO INC /NY/ | 3.2M | 94.6M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.8M | 80.8M | 新進 | 新進 |
| Jupiter Topco LLC | 2.4M | 71.0M | 新進 | 新進 |
| Invesco Ltd. | 2.3M | 67.4M | 新進 | 新進 |
| Point72(柯恩) Point72 Asset Management, L.P. | 1.7M | 50.5M | 新進 | 新進 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 1.7M | 49.7M | 新進 | 新進 |
| ALLIANCEBERNSTEIN L.P. | 1.9M | 46.8M | 新進 | 新進 |
| STATE STREET CORP | 1.5M | 43.3M | 新進 | 新進 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.5M | 43.0M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4M | 39.9M | 新進 | 新進 |
| Nuveen, LLC | 1.4M | 39.7M | 新進 | 新進 |
| MORGAN STANLEY | 1.1M | 31.0M | 新進 | 新進 |
| UBS Group AG | 976K | 28.6M | 新進 | 新進 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 931K | 27.3M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 923K | 27.1M | 新進 | 新進 |
| 12 West Capital Management LP | 903K | 26.5M | 新進 | 新進 |
| FRANKLIN RESOURCES INC | 818K | 24.0M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 800K | 23.5M | 新進 | 新進 |
| Champlain Investment Partners, LLC | 734K | 21.5M | 新進 | 新進 |
| VOYA INVESTMENT MANAGEMENT LLC | 733K | 21.5M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 193 +24 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 193 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 74.8M · 86.0% |
| 合計季末市值 | 2.2B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 6.1M |
|---|---|
| 與上期比 | -10.5% |
| 佔流通股數 | 6.98% |
| 日均成交量 | 2.4M |
| 回補天數 | 2.5 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 6.1M | -10.5% | 6.98% | 2.4M | 2.5 |
| 2026-08-14 | 6.8M | -1.0% | 7.80% | 1.8M | 3.9 |
| 2026-07-31 | 6.8M | +16.6% | 7.88% | 1.0M | 6.6 |
| 2026-07-15 | 5.9M | +13.4% | 6.75% | 1.4M | 4.2 |
| 2026-06-30 | 5.2M | +22.9% | 5.95% | 3.0M | 1.7 |
| 2026-06-15 | 4.2M | +15.9% | 4.85% | 1.1M | 3.7 |
| 2026-05-29 | 3.6M | +4.5% | 4.18% | 1.3M | 2.9 |
| 2026-05-15 | 3.5M | -20.2% | 4.00% | 1.1M | 3.3 |
| 2026-04-30 | 4.4M | -21.4% | 5.01% | 1.1M | 3.9 |
| 2026-04-15 | 5.5M | -7.7% | 6.38% | 1.2M | 4.6 |
| 2026-03-31 | 6.0M | +8.1% | 6.91% | 2.0M | 3.1 |
| 2026-03-13 | 5.6M | +2.0% | 6.40% | 1.1M | 5.2 |
| 2026-02-27 | 5.5M | +19.6% | 6.27% | 1.2M | 4.4 |
| 2026-02-13 | 4.6M | -7.9% | 5.24% | 2.8M | 1.7 |
| 2026-01-30 | 5.0M | +42.4% | 5.69% | 843K | 5.9 |
| 2026-01-15 | 3.5M | +9.9% | 4.00% | 830K | 4.2 |
| 2025-12-31 | 3.2M | +118.3% | 3.64% | 1.0M | 3.1 |
| 2025-12-15 | 1.4M | +18.8% | 1.67% | 503K | 2.9 |
| 2025-11-28 | 1.2M | +10.7% | 1.40% | 695K | 1.8 |
| 2025-11-14 | 1.1M | +127.6% | 1.27% | 500K | 2.2 |
| 2025-10-31 | 484K | +20.6% | 0.56% | 242K | 2.0 |
| 2025-10-15 | 401K | -47.6% | 0.46% | 385K | 1.0 |
| 2025-09-30 | 767K | +28.6% | 0.88% | 448K | 1.7 |
| 2025-09-15 | 596K | +9.3% | 0.69% | 323K | 1.9 |
| 2025-08-29 | 545K | +17.7% | 0.63% | 360K | 1.5 |
| 2025-08-15 | 463K | +100.0% | 0.53% | 1.1M | 1.0 |